The Brain Tumor Center at Wake Forest (Frame 3)

Therapy of brain tumors is available through a collaboration combining the strengths of the Departments of Radiation Medicine, Medical Oncology, and Neurosurgery. Advanced radiologic techniques, including functional magnetic resonance imaging (fMRI) and positron emission tomography (PET), are available through close collaboration with the Wake Forest University

The Wake Forest University Brain Tumor Center congratulates Dr. Edward Shaw for his service as President of the international brain tumor professional organization the Society for Neuro-Oncology from 2001-2003.

School of Medicine Neuroradiology Section. In addition, the Neuropathology Section provides pathologic consultations by dedicated Neuropathologists. A staff of eight nurse practicioners and physicians assitants are available to assist in the care of patients with tumors of the Central Nervous System and to provide support for their families or other care givers.

Wake Forest is a member of the major national brain tumor therapy consortia including New Approaches to Brain Tumor Therapy (NABTT) and the Radiation Therapy Oncology Group (RTOG), and the American College of Surgeons Oncology Group (ACOSOG) and offers a wide variety of protocols for brain tumor therapy sponsored by these groups and developed internally. Patients can also be treated outside of formal research protocols when appropriate.

The Neurosurgery Department specializes in the surgical techniques developed to allow safe removal of brain tumors including microsurgery and stereotactic guidance. Minimally invasive techniques for the treatment and biopsy of brain tumors are also available.

The Wake Forest University Comprehensive Cancer Center (WFUCCC) is one of only 41 National Cancer Institute designated Cancer Centers. The WFU Brain Tumor Center of Excellence is one of the three clinical centers of excellence in the WFUCCC. The WFU Brain Tumor Center of Excellence is the research arm of the WFU Brain Tumor Center and is headed by Dr. Waldemar Debinski, co-inventor of IL13-PE38, one of the most promising agents in current clinical trials. Wake Forest University School of Medicine is also active in basic science research devoted to understanding the causes and advancing the therapy of brain tumors.

For more information about how you can contribute to the cure for brain tumors click here.

Brain Tumor Referrals

Physicians may refer patients to the Brain Tumor Center for prompt evaluation by contacting the Physicians Access Line at any time or by contacting the offices of any of the Center members listed below.

Patients or families may refer inquiries regarding brain tumors to Wake Forest/Baptist Hospital's Health On-Call Service.

For more information on brain tumor referrals here at Wake Forest also see the Wake Forest Brain Tumor Center Referrals Homepage.

Brain Tumor Center Clinical Members

Neuro-Ophthalmology

Timothy J. Martin, M.D.

For more information about the treatment of tumors of the brain, spine, and peripheral nerves see the links below.

The Wake Forest Neurosurgery Brain Tumor Index Comprehensive Internet links to information about brain tumors
The New WHO Classsification of Central Nervous System Tumors
Astrocytic Tumor Grading Systems
Mutations in Astrocytic Lineage Tumors
Benign brain and spine tumors such as meningioma, epidermoid, dermoid, hemangioblastoma, colloid cyst, subependymal giant cell astrocytoma, pleomorphic xanthoastrocytoma, and craniopharyngioma.
Acoustic neuroma and other cerebellopontineangle (cpa) and skull base tumors
Pituitary tumor (adenoma, carcinoma) information
Neurofibromatosis (type I, Von Recklinghausen's disease) information
Tuberous sclerosis resources
Von Hippel-Lindau disease resources
Spine tumor information

Click on the Medical Center logo at right to go to the Medical School Homepage or the Neurosurgery logo at left to return to the Wake Forest Neurosurgery Homepage.
You must read our important disclaimer before using this site.
040715 Stephen B. Tatter, M.D., Ph.D.